Estrogen, acting through estrogen receptors (nuclear receptors ERα and ERβ and membrane receptors GPER), was extensively deregulated during the development and progression of esophageal cancer [32], gastric cancer [33], and colon cancer [34]. The gene discussed is ESR2; the disease is gastric cancer.